Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis UCB

Eagle - 15+ consecutive years of dividend increases

Max Ratio

0.49

Dividend Yield

0.80 %

5Y Dividend Growth

12.00 %

Consecutive Years

15 years

5Y Average Payout Ratio

30.44 %

Dividend History UCB

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 0.80 %
Consecutive Years 15
Forward Annual Dividend 1.93 EUR
Consistent Years 20
Dividend CAGR 3Y 2.31 %
Continuous Dividends
Dividend CAGR 5Y 2.36 %
Payout Ratio TTM 17.82 %
Dividend CAGR 10Y 2.01 %
Ex Dividend Date 04/25/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth UCB

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin UCB

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income UCB

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM UCB

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio UCB

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

UCB SA UCB

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself UCB

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 34.97
Forward PE 22.94
Enterprise Value Revenue 6.78
Price Sales TTM 6.66
Enterprise Value EBITDA 19.81
Price Book MRQ 4.70

UCB SA Dividends: 0.41 % Yield, History, Payment Schedule

UCB
Current price
239.90 EUR +1.2 EUR (+0.50%)
Last closed 239.80 EUR
ISIN BE0003739530
Sector Healthcare
Industry Biotechnology
Exchange Euronext Brussels
Capitalization 45 691 756 737 EUR
Yield for 12 month +29.50 %
1Y
3Y
5Y
10Y
15Y
UCB
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+6 165 572 870 EUR

Last Year

+5 263 587 242 EUR

Current Quarter

+3 494 693 205 EUR

Last Quarter

+3 368 415 217 EUR

Current Year

+4 409 707 514 EUR

Last Year

+3 552 821 168 EUR

Current Quarter

+2 570 659 039 EUR

Last Quarter

+2 349 171 457 EUR
EBITDA 1 856 085 981 EUR
Operating Margin TTM 19.90 %
Price to Earnings 34.97
Return On Assets TTM 4.63 %
PEG Ratio 2.43
Return On Equity TTM 14.30 %
Wall Street Target Price 222.22 EUR
Revenue TTM 6 863 108 422 EUR
Book Value 51.08 EUR
Revenue Per Share TTM
Dividend Share 1.39 EUR
Quarterly Revenue Growth YOY 24.90 %
Dividend Yield 0.80 %
Gross Profit TTM 5 036 086 358 EUR
Earnings per share 6.88 EUR
Diluted Eps TTM 6.88 EUR
Most Recent Quarter II 2025
Quarterly Earnings Growth YOY 130.20 %
Profit Margin 19.45 %

Technical Indicators UCB

For 52 Weeks

128.78 EUR 263.78 EUR
50 Day MA 237.68 EUR
Shares Short Prior Month
200 Day MA 189.70 EUR
Short Ratio
Shares Short
Short Percent